IIM
KALV

Ironwood Investment Management’s KalVista Pharmaceuticals KALV Stock Holding History

Ironwood Investment Management’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$336K Hold
16,711
– – 0.14% 134
2025
Q4 		$270K Hold
16,711
– – 0.11% 138
2025
Q3 		$204K Hold
16,711
– – 0.09% 159
2025
Q2 		$189K Buy
16,711
+5,223
+45% +$63.9K 0.09% 148
2025
Q1 		$133K Hold
11,488
– – 0.07% 149
2024
Q4 		$97.3K Hold
11,488
– – 0.05% 160
2024
Q3 		$133K Hold
11,488
– – 0.06% 161
2024
Q2 		$135K Hold
11,488
– – 0.07% 156
2024
Q1 		$136K Buy
+11,488
New +$153K 0.07% 163

Other funds holding KALV

VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ironwood Investment Management's KALV Position: Q1 2026 in Review

Ironwood Investment Management held its KalVista Pharmaceuticals (KALV) position steady in Q1 2026 at 16,711 shares worth $336K. The position accounts for 0.14% of the portfolio, ranked #134.

Ironwood Investment Management first reported a position in KALV in Q1 2024 and has held it in 9 quarters since. 184 funds tracked by Wall St. Rank hold KALV as of Q1 2026.

  • Ironwood Investment Management held 16,711 shares of KalVista Pharmaceuticals worth $336K as of Q1 2026.
  • Ironwood Investment Management left its KalVista Pharmaceuticals share count unchanged in Q1 2026.
  • KalVista Pharmaceuticals made up 0.14% of Ironwood Investment Management's portfolio in Q1 2026, its #134 holding.
  • Ironwood Investment Management first reported a position in KalVista Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • 184 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q1 2026.

Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.